Merck KGaA says FY profit to fall to lower half of target range

Merck signs $5.5 billion deal with Daiichi for cancer therapy development

Germany's Merck flags steeper drop in earnings

Moderna/Merck begins late-stage study of skin cancer vaccine combination

White House says it will win Merck lawsuit, defends Medicare drug negotiations

CEO of Germany's Merck: decoupling from China would be at huge economic cost

Merck sues US government to halt Medicare drug price negotiation

Cancer vaccines poised to unlock 'new treatment paradigm' with Merck/Moderna data

Germany's Merck flags decline in operating profit of up to 10% in 2023